Your browser doesn't support javascript.
loading
Mitochondria: A Galaxy in the Hematopoietic and Leukemic Stem Cell Universe.
Panuzzo, Cristina; Jovanovski, Aleksandar; Pergolizzi, Barbara; Pironi, Lucrezia; Stanga, Serena; Fava, Carmen; Cilloni, Daniela.
Afiliação
  • Panuzzo C; Department of Clinical and Biological Sciences, University of Turin, Orbassano, 10043, Italy.
  • Jovanovski A; Department of Clinical and Biological Sciences, University of Turin, Orbassano, 10043, Italy.
  • Pergolizzi B; Department of Clinical and Biological Sciences, University of Turin, Orbassano, 10043, Italy.
  • Pironi L; Department of Clinical and Biological Sciences, University of Turin, Orbassano, 10043, Italy.
  • Stanga S; Department of Neuroscience Rita Levi Montalcini, Turin 10124, Italy.
  • Fava C; Department of Clinical and Biological Sciences, University of Turin, Orbassano, 10043, Italy.
  • Cilloni D; Department of Clinical and Biological Sciences, University of Turin, Orbassano, 10043, Italy.
Int J Mol Sci ; 21(11)2020 May 30.
Article em En | MEDLINE | ID: mdl-32486249
ABSTRACT
Mitochondria are the main fascinating energetic source into the cells. Their number, shape, and dynamism are controlled by the cell's type and current behavior. The perturbation of the mitochondrial inward system via stress response and/or oncogenic insults could activate several trafficking molecular mechanisms with the intention to solve the problem. In this review, we aimed to clarify the crucial pathways in the mitochondrial system, dissecting the different metabolic defects, with a special emphasis on hematological malignancies. We investigated the pivotal role of mitochondria in the maintenance of hematopoietic stem cells (HSCs) and their main alterations that could induce malignant transformation, culminating in the generation of leukemic stem cells (LSCs). In addition, we presented an overview of LSCs mitochondrial dysregulated mechanisms in terms of (1) increasing in oxidative phosphorylation program (OXPHOS), as a crucial process for survival and self-renewal of LSCs,(2) low levels of reactive oxygen species (ROS), and (3) aberrant expression of B-cell lymphoma 2 (Bcl-2) with sustained mitophagy. Furthermore, these peculiarities may represent attractive new "hot spots" for mitochondrial-targeted therapy. Finally, we remark the potential of the LCS metabolic effectors to be exploited as novel therapeutic targets.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células-Tronco Hematopoéticas / Leucemia / Neoplasias Hematológicas / Mitocôndrias Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células-Tronco Hematopoéticas / Leucemia / Neoplasias Hematológicas / Mitocôndrias Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália